Inhibition of tumor growth and angiogenesis by vitamin D3 agents in murine renal cell carcinoma

Journal of Urology

Volumn 160, Issue 1, 1998, Pages 247-251

  Fujioka, Tomoaki ^a   Hasegawa, Michihiko ^a   Ishikura, Koichi ^a   Matsushita, Yasushi ^a   Sato, Masatsugu ^a   Tanji, Susumu ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Angiogenesis inhibitor; Cholecarciferol; Murine renal tumor

Indexed keywords

COLECALCIFEROL DERIVATIVE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; CYTOTOXICITY; DRUG INHIBITION; FEMALE; HYPERCALCEMIA; KIDNEY CARCINOMA; METASTASIS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; WEIGHT REDUCTION;

EID: 0032323116     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)63098-2     Document Type: Article

References (23)

1. Folkman, J.: Tumor angiogenesis; therapeutic implication. N. Engl. J. Med., 285: 1182, 1971.
2. Liotta, L., Kleinerman, J. and Saidel, G.: Quantitative relationship of intravascular tumor cells, tumor vessels, and pulmonary metastasis following tumor implantation. Cancer Res., 34: 997, 1974.
3. Blood, C. H. and Zetter, B. R.: Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim. Biophys. Acta, 1032: 89, 1990.
4. Campbell, S. C.: Advances in angiogenesis research: relevance to urological oncology. J. Urol., 158: 1663, 1997.
5. Haussler, M. R. and McCain, T. A.: Basic and clinical concepts related to vitamin D metabolism and action. N. Engl. J. Med., 297: 974, 1977.
6. Norman, A. W., Roth, J. and Orci, L.: The vitamin endocrine system: steroid metabolism, hormone receptors, and biological response (calcium binding proteins). Endocr. Rev., 3: 331, 1982.
7. Holick, M. F., Semmler, E. J., Schonoes, H. K. and Deluca, H. F.: 1α-hydroxy derivative of vitamin D3: a highly potent analogue of 1α,25-dihydroxyvitamin D3. Science, 180: 190, 1973.
8. Okada, K., Nagura, Y., Takahashi, S. and Hatano, M.: Influence of 1α-hydroxy vitamin D3 (0.25 μg./day) and calcium carbonate on patients with chronic renal failure at the predialytic stage. JJN, 31: 675, 1989.
9. Omori H., Shiraki, M., Hayashi, Y., Hoshino, T., Onaya, T., Miyazaki, S., Kurosawa, H., Nakamura, T. and Ogawa, N.: Effects of 1α-hydroxyvitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis. Calcif. Tissue Int., 54: 370, 1994.
10. Abe, E., Miyaura, C., Sakagami, H., Takada, M., Konno, K., Yamazaki, T., Yoshiki, S. and Suda, T.: Differentiation of mouse myeloid leukemia cells induced by 1a,25-dihydroxyvitamin D3. Proc. Nat. Acad. Sci. USA, 78: 4990, 1981.
11. Brumbaugh, P. F. and Haussler, M. R.: 1α,25-dihydroxy-cholecalciferol receptors in intestine. J. Biol. Chem., 249: 1251, 1974.
12. 2 vitamin D3 receptor gene regulation and genetic circuity. FASEB, 2: 3043, 1988.
13. Franceschi, R. T., Linson, C. J., Peter, C. J. and Romano, P. R.: Regulation of cellular adhesion and fibronectin synthesis by 1-α-dihydroxyvitamin D3. J. Biol. Chem., 262: 4165, 1987.
14. Oikawa T., Hirotani, K., Ogasawara, H., Katayama, T., Nakamura, O., Iwaguchi, T. and Hiragun, A.: Inhibition of angiogenesis by vitamin D3 analogues. Eur. J. Pharmacol., 178: 247, 1990.
15. Fujioka, T., Hasegawa, M., Ogiu, K., Matsushita, Y., Sato M. and Kubo, T.: Antitumor effects of angiogenesis inhibitor O-(chloroacetyl-caebamol) fumagillol (TNP-470) against murine renal cell carcinoma. J. Urol., 155: 1775, 1996.
16. Studzinski, G. P. and Morre, D. C.: Sunlight-Can it prevent as well as cause cancer? Cancer Res., 55:4014, 1995.
17. Okamoto, T., Fujioka, T. and Horiuchi, S.: A study of the metabolism of vitamin S in patients with renal cell carcinoma - with special reference to serum concentration of 1α,25-(OH)D3 and its clinical significance. Jpn. J. Urol., 82: 890, 1991.
18. Marolagas, S. C., Yu, X-P., Girasole, G. and Bellido, T.: Vitamin D and the hematolymhopoietic tissues: a 1994 update. Semin. Nephrol., 14: 129,1994.
19. Weidner, N., Semple, J. P., Welch, W. R. and Folkman, J.: Tumor angiogenesis and metastasis correlation in invasive breast carcinoma. N. Engl. J. Med., 324: 1, 1991.
20. Weidner, N., Carroll, P. R., Flax, J., Blumenfeld, W. and Folkman, J.: Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am. J. Pathol., 143: 401, 1993.
21. Folkman, J.: How is blood vessel growth regulated in normal and neoplastic tissue? Cancer Res., 46:467, 1986.
22. Liotta, L. A., Steeg, P. S. and Stetler-Stevenson, W. G.: Cancer metastasis and angiogenesis: an imbalance of positive and regulation. Cell, 64: 327, 1991.
23. Yamaoka, M., Yamamoto, T., Masaki, T., Ikeyama, S., Sudo, K. and Fujita, T.: Inhibition of tumor growth and metastasis of rodent tumor by the angiogenesis inhibitor O-(chroacetyl- carbamoyl)fumagillol (TNP-470;AGM-1470). Cancer Res., 53: 4267, 1993.